bioRxiv · 10.1101/2021.06.05.447195
Quantification of Antisense Oligonucleotides by Splint Ligation and Quantitative Polymerase Chain Reaction
Abstract
Reliable detection and quantification of antisense oligonucleotides (ASOs) in experimental and clinical specimens is essential to understand the biological function of novel oligonucleotide-based therapeutics. In this study, we describe a method to detect and quantify ASOs in biological samples, whereby the ASO acts as a splint to direct the ligation of complementary probes and quantitative real-time PCR was used to monitor ligation products. Low levels of 2'-O-MOE gapmer ASO in serum, liver, kidney, lung, heart, muscle, and brain tissues can be detected over a 6-log linear range for detection using this method. This method allows quantification of various types of chemically modified ASOs, including PS linkage, 2'-OMe, 2'-O-MOE, locked nucleic acid (LNA), and siRNA. This method does not require probe modifications, and can be performed using standard laboratory equipment; making it a fast, sensitive, and reliable technique that can be widely applied. This detection method may find potential applications in detection of therapeutic oligonucleotides in biological samples.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Shin, M., Krishnamurthy, P. M., Watts, J. K.. 2021-06-05. Quantification of Antisense Oligonucleotides by Splint Ligation and Quantitative Polymerase Chain Reaction. https://doi.org/10.1101/2021.06.05.447195
Cite the original work for its findings. Save a collection to share your selection of sources.